Neogen Corporation is a company that specializes in developing and marketing innovative solutions for food and animal safety
Its product portfolio includes a wide range of diagnostic tests, natural antiseptics, and other technologies designed to detect foodborne pathogens, allergens, and other contaminants. Neogen serves diverse markets, including food processors, restaurants, and agriculture. By providing tools that help ensure the safety and quality of food products, Neogen plays a critical role in promoting public health and supporting higher standards in food production and processing.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSEBSX) and the best and worst performers in the medical devices & supplies - diversified industry.
Life sciences company Neogen (NASDAQNEOG) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $231.3 million. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Shares of Tilray Brands, Inc. (NASDAQTLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 38,972.32 while the NASDAQ rose 0.40% to 16,319.23. The S&P 500 also rose, gaining, 0.32% to 5,219.29.
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar Technologies, Ltd. (NASDAQMAXN) fell sharply in today’s pre-market trading.
Companies Reporting Before The Bell • Tilray Brands (NASDAQTLRY) is projected to report quarterly loss at $0.05 per share on revenue of $198.62 million.
The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, with the index remaining in the "Greed" zone on Monday. U.S. stocks closed little changed on Monday, ahead of key inflation data. Data on consumer and producer price indexes for March will be released this week.
U.S. stocks traded mostly lower midway through trading, with the Dow Jones falling around 180 points on Tuesday. The Dow traded down 0.49% to 37,499.41 while the NASDAQ rose 0.07% to 14,853.45. The S&P 500 also fell, dropping, 0.16% to 4,755.70.
